Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
euglena Co's earnings before interest and taxes (EBIT) for the
three
months ended in Dec. 2025 was 円124 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was 円2,999 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
euglena Co's annualizedROC % for the quarter that ended in Dec. 2025 was 0.00%.
euglena Co's annualizedROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 5.95%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
euglena Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 5.61%.
euglena Co (TSE:2931) EBIT Explanation
1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
euglena Co's annualizedROC % for the quarter that ended in Dec. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
euglena Co EBIT Related Terms
euglena Co EBIT Historical Data
* Premium members only.
The historical data trend for euglena Co's EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, euglena Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
euglena Co EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, euglena Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where euglena Co's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,999 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
euglena Co (TSE:2931) has a EBIT of 円2,999 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on euglena Co.
Is euglena Co's EBIT too high?
euglena Co's current EBIT is 円2,999 Mil. Overall, euglena Co has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does euglena Co's EBIT compare to PG and CL?
euglena Co's EBIT of 円2,999 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Consumer Packaged Goods company?
A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on euglena Co. euglena Co's current EBIT is 円2,999 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is euglena Co stock overvalued right now?
Based on GuruFocus' analysis, euglena Co (TSE:2931) is currently considered Possible Value Trap. The stock's GF Value™ is 円501.49, compared to a current price of 円351.00 — trading 30% below its estimated fair value. The current EBIT is 円2,999 Mil. euglena Co's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For euglena Co (TSE:2931), the current EBIT is 円2,999 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is euglena Co (TSE:2931) Overvalued in 2026?
Based on GuruFocus' analysis, euglena Co stock appears to be undervalued.
The current stock price of 円351.00 is trading 30% below its estimated GF Value™ of 円501.49.
GuruFocus considers euglena Co to be Possible Value Trap.
Key valuation signals for TSE:2931:
EBIT: 円2,999 Mil
GF Value™: 円501.49 vs. price of 円351.00 (30% below fair value)
No single metric tells the full story. See the TSE:2931 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
euglena Co Ltd is a biotechnology company that researches, develops, produces, and markets microalgae. The company focuses on commercializing its algae research for a variety of uses, including functional foods and cosmetics. Euglena also researches ways to use its microalgae for carbon capture and biofuel production. The company operates in three segments: Healthcare Business, Biofuel Business, and Other Businesses.
64GF Score
Get the complete analysis for TSE:2931
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2931 has been successfully added to your 
